243 related articles for article (PubMed ID: 19581286)
21. PADI4 Epigenetically Suppresses p21 Transcription and Inhibits Cell Apoptosis in Fibroblast-like Synoviocytes from Rheumatoid Arthritis Patients.
Fan L; Zong M; Gong R; He D; Li N; Sun LS; Ye Q; Yu S
Int J Biol Sci; 2017; 13(3):358-366. PubMed ID: 28367100
[TBL] [Abstract][Full Text] [Related]
22. Recognition of the N-terminal histone H2A and H3 peptides by peptidylarginine deiminase IV.
Saiki M; Watase M; Matsubayashi H; Hidaka Y
Protein Pept Lett; 2009; 16(9):1012-6. PubMed ID: 19508226
[TBL] [Abstract][Full Text] [Related]
23. Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4.
Arita K; Shimizu T; Hashimoto H; Hidaka Y; Yamada M; Sato M
Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5291-6. PubMed ID: 16567635
[TBL] [Abstract][Full Text] [Related]
24. Histone Deacetylase 1 (HDAC1) Negatively Regulates Thermogenic Program in Brown Adipocytes via Coordinated Regulation of Histone H3 Lysine 27 (H3K27) Deacetylation and Methylation.
Li F; Wu R; Cui X; Zha L; Yu L; Shi H; Xue B
J Biol Chem; 2016 Feb; 291(9):4523-36. PubMed ID: 26733201
[TBL] [Abstract][Full Text] [Related]
25. Histone arginine methylation and its dynamic regulation.
Wysocka J; Allis CD; Coonrod S
Front Biosci; 2006 Jan; 11():344-55. PubMed ID: 16146736
[TBL] [Abstract][Full Text] [Related]
26. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation.
Wang Y; Li M; Stadler S; Correll S; Li P; Wang D; Hayama R; Leonelli L; Han H; Grigoryev SA; Allis CD; Coonrod SA
J Cell Biol; 2009 Jan; 184(2):205-13. PubMed ID: 19153223
[TBL] [Abstract][Full Text] [Related]
27. Autodeimination of protein arginine deiminase 4 alters protein-protein interactions but not activity.
Slack JL; Jones LE; Bhatia MM; Thompson PR
Biochemistry; 2011 May; 50(19):3997-4010. PubMed ID: 21466234
[TBL] [Abstract][Full Text] [Related]
28. Dynamic histone acetylation/deacetylation with progesterone receptor-mediated transcription.
Aoyagi S; Archer TK
Mol Endocrinol; 2007 Apr; 21(4):843-56. PubMed ID: 17227884
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene.
Liu JC; Baker RE; Chow W; Sun CK; Elsholtz HP
Mol Endocrinol; 2005 Jul; 19(7):1904-17. PubMed ID: 15731170
[TBL] [Abstract][Full Text] [Related]
30. Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo.
Liu XF; Bagchi MK
J Biol Chem; 2004 Apr; 279(15):15050-8. PubMed ID: 14722073
[TBL] [Abstract][Full Text] [Related]
31. Increased PADI4 expression in blood and tissues of patients with malignant tumors.
Chang X; Han J; Pang L; Zhao Y; Yang Y; Shen Z
BMC Cancer; 2009 Jan; 9():40. PubMed ID: 19183436
[TBL] [Abstract][Full Text] [Related]
32. Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells.
Sharma D; Blum J; Yang X; Beaulieu N; Macleod AR; Davidson NE
Mol Endocrinol; 2005 Jul; 19(7):1740-51. PubMed ID: 15746193
[TBL] [Abstract][Full Text] [Related]
33. Relationship between DNA methylation, histone H4 acetylation and gene expression in the mouse imprinted Igf2-H19 domain.
Grandjean V; O'Neill L; Sado T; Turner B; Ferguson-Smith A
FEBS Lett; 2001 Jan; 488(3):165-9. PubMed ID: 11163765
[TBL] [Abstract][Full Text] [Related]
34. Deimination stabilizes histone H2A/H2B dimers as revealed by electrospray ionization mass spectrometry.
Shimoyama S; Nagadoi A; Tachiwana H; Yamada M; Sato M; Kurumizaka H; Nishimura Y; Akashi S
J Mass Spectrom; 2010 Aug; 45(8):900-8. PubMed ID: 20648673
[TBL] [Abstract][Full Text] [Related]
35. Autoregulation of mouse histone deacetylase 1 expression.
Schuettengruber B; Simboeck E; Khier H; Seiser C
Mol Cell Biol; 2003 Oct; 23(19):6993-7004. PubMed ID: 12972616
[TBL] [Abstract][Full Text] [Related]
36. COX-2 expression induced by diesel particles involves chromatin modification and degradation of HDAC1.
Cao D; Bromberg PA; Samet JM
Am J Respir Cell Mol Biol; 2007 Aug; 37(2):232-9. PubMed ID: 17395887
[TBL] [Abstract][Full Text] [Related]
37. Expression of peptidylarginine deiminase type 4 in ovarian tumors.
Wang L; Chang X; Yuan G; Zhao Y; Wang P
Int J Biol Sci; 2010 Aug; 6(5):454-64. PubMed ID: 20827398
[TBL] [Abstract][Full Text] [Related]
38. Citrullination of inhibitor of growth 4 (ING4) by peptidylarginine deminase 4 (PAD4) disrupts the interaction between ING4 and p53.
Guo Q; Fast W
J Biol Chem; 2011 May; 286(19):17069-78. PubMed ID: 21454715
[TBL] [Abstract][Full Text] [Related]
39. Peptidylarginine Deiminase IV Regulates Breast Cancer Stem Cells via a Novel Tumor Cell-Autonomous Suppressor Role.
Moshkovich N; Ochoa HJ; Tang B; Yang HH; Yang Y; Huang J; Lee MP; Wakefield LM
Cancer Res; 2020 Jun; 80(11):2125-2137. PubMed ID: 32265227
[TBL] [Abstract][Full Text] [Related]
40. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
